Blog
RSS FeedPosted by Michael Wonder on 28 Jan 2026
New hope for people with breathing condition, COPD, as NICE approves innovative treatment
26 January 2026 - Almost 30,000 people in England with a respiratory disease called COPD (chronic obstructive pulmonary disease) could ...
Posted by Michael Wonder on 27 Jan 2026
EMA publishes agenda for 26-29 January 2026 CHMP meeting
26 January 2026 - The EMA has published a draft agenda for this week's CHMP meeting. ...
Posted by Michael Wonder on 26 Jan 2026
Thousands could benefit from new take-at-home treatment for advanced prostate cancer
23 January 2026 - NICE recommends life-extending daily pill which offers hope for people who cannot take standard treatment. ...
Posted by Michael Wonder on 23 Jan 2026
What role does equity play in Australia’s health technology assessment processes? A review of the PBAC recommendations regarding vaccines
23 January 2026 - The Australian PBAC makes recommendations to the government on the listing of vaccines on the National Immunisation ...
Posted by Michael Wonder on 22 Jan 2026
Thousands living with lupus offered hope from twice yearly infusion
22 January 2026 - NICE approves breakthrough combination treatment that restores normal kidney function in almost half of patients with lupus ...
Posted by Michael Wonder on 19 Jan 2026
SMC - January 2026 decisions
19 January 2026 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 09 Jan 2026
Agenda for the March 2026 PBAC meeting (9 January 2026)
9 January 2026 - The Department of Health has published an updated agenda for the March 2026 PBAC agenda (version ...
Posted by Michael Wonder on 06 Jan 2026
NICE recommends new treatment option for highly active multiple sclerosis
2 January 2026 - Thousands of people living with a form of multiple sclerosis will benefit from greater treatment choice, following ...
Posted by Michael Wonder on 05 Jan 2026
SMC - December 2025 decisions
8 December 2025 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 25 Dec 2025
Korea to expand Keytruda reimbursement to 11 new cancer uses starting 2026
24 December 2025 - Korea’s national health insurance program will broaden reimbursement for MSD’s blockbuster PD-1 inhibitor Keytruda in a ...
Posted by Michael Wonder on 24 Dec 2025
Thousands more people with advanced bowel cancer to benefit as NICE approves bevacizumab biosimilars
24 December 2025 - More than 7,000 people in England will now be able to access to a life-extending treatment for ...
Posted by Michael Wonder on 24 Dec 2025
Public Summary Documents – September 2025 PBAC meeting
24 December 2025 - The Public Summary Documents (positive recommendations) from the September 2025 PBAC meeting are now available. ...
Posted by Michael Wonder on 20 Dec 2025
Two new treatments recommended for people with breast cancer
19 December 2025 - Breast Cancer Network Australia welcomes the PBAC's recommendation to subsidise two important medicines on the PBS: Veoza ...
Posted by Michael Wonder on 20 Dec 2025
Weight loss drug Wegovy close to PBS approval
19 December 2025 - New medicines are revolutionising the management of serious medical conditions. Now a recommendation has been made about ...
Posted by Michael Wonder on 20 Dec 2025
The IQWiG methods: new version is effective immediately
19 December 2025 - With the General Methods 8.0, the new IQWiG methodology for determining minimum staffing levels for service ...